Acurx Pharmaceuticals, Inc. (ACXP) stock
ACXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.96−0.03 (-2.54%)
Close on Nov 13, 2026Market cap $5.06MP/E –Yield –
Acurx Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Acurx Pharmaceuticals's enterprise value was -$5.83M on Nov 11, 2026, against $1.08M a year earlier. Over the last 5 years it ranged from -$5.83M to $53.10M, with a median of $21.70M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$5.83M | – |
| 2025 | Dec 31, 2025 | -$1.42M | -121.4% |
| 2024 | Dec 31, 2024 | $6.66M | -81.2% |
| 2023 | Dec 29, 2023 | $35.42M | +11.5% |
| 2022 | Dec 30, 2022 | $31.76M | +8.4% |
| 2021 | Dec 31, 2021 | $29.30M | – |
See a number that looks wrong?